Trial Profile
Effect of quercetin on pharmacokinetics of diclofenac sodium (DIC) in healthy volunteers: An open-label study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Chronic obstructive pulmonary disease; Thromboembolism
- Focus Pharmacokinetics
- 18 May 2018 New trial record